Apiklis | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

28 results for “Apiklis”

Trials

Agilis RF TSP Early Feasibility Study

60 participants · First posted Jan 23, 2026

Efficacy and Safety Study on Agilis NxT Introducer in AF Patients

130 participants · First posted May 4, 2007

Tolerance and Efficacy of Amiklin Administration During Nosocomial Infections Complicating COVID-19 in the ICU

1,053 participants · First posted Aug 22, 2022

Drugs

APL 2006 gene therapy (Apellis Pharmaceuticals)

APL 1030 gene therapy (Apellis Pharmaceuticals)

Organizations

Apellis Pharmaceuticals

United States

APELLIS PHARMACEUTICALS, INC

United States

APTALIS PHARMA US, INC.

United States

News

View all 19 →

FAS Investigates Teva and Grotex for Alleged Unfair Competition Over Generic Apixaban Launch

Russia Launches Antitrust Cases Over Generic Versions of Pfizer's Eliquis

Apellis' Syfovre Approved in Australia for Geographic Atrophy

Page 1 of 3